Overview

The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if standardizing fluid intake in a clinic setting will reduce variability of individual voiding parameters and potentially serve as a way to limit patient exposure in the initial assessment of efficacy of compounds being developed for Overactive Bladder.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Tolterodine Tartrate